Image credit: Suppled photo
EFG Hermes, an EFG Holding company and the leading investment bank in the Middle East and North Africa, announced it has acted as the Sole M&A Financial Advisor on a landmark $190m minority stake investment in Alameda Healthcare, one of Egypt’s top private healthcare providers.
Read- EFG Holding posts resilient Q1 ’25 results despite FX impact
The investment was led by Development Partners International (DPI) in partnership with a consortium of institutional investors and development finance institutions. Following the transaction, Dr Fahad Khater, Chairman of Alameda, will remain the majority shareholder. The deal, primarily structured as a capital increase, is pending regulatory approvals and is expected to close in Q3 2025.
This marks the largest foreign direct investment in Egypt’s healthcare sector to date, reinforcing investor confidence in Egypt’s high-growth, resilient industries. The transaction will inject foreign currency into Egypt’s banking system and support Alameda’s expansion both locally and in the GCC markets.
Strategic expansion supported by capital injection
“This is a proud moment for EFG Hermes as we continue to deliver on our promise to guide clients through transformational transactions,” said Maged El Ayouti, Co-Head of Investment Banking at EFG Hermes.
“Securing a $190m investment for one of the region’s fastest-growing healthcare platforms reflects our strong advisory capabilities and deep market expertise.”
Alameda, under Dr Khater’s leadership, plans to use the proceeds to scale its hospital operations and increase clinical capacity. The funding will support expansion in Egypt, Saudi Arabia, the UAE, and other GCC countries, bolstering its position as a regional healthcare leader.
El Ayouti added that the firm’s advisory role in this transaction is part of a broader track record of M&A excellence. Over the past 18 months, EFG Hermes has advised on M&A deals worth more than $2.5bn. Since the start of 2025, the investment bank has closed four M&A transactions, along with seven DCM and seven ECM deals across Egypt, the UAE, Saudi Arabia, and Oman.
The investment represents a key milestone in both Alameda’s growth journey and EFG Hermes’s continued dominance in regional capital markets.
